N-5,10-methylenetetrahydrofolate reductase deficiency and schizophrenia: a working hypothesis.
D000293:Adolescent; D004298:Dopamine / Q000378:metabolism; D005260:Female; D005347:Fibroblasts / Q000201:enzymology; D005492:Folic Acid / Q000378:metabolism / Q000627:therapeutic use; D006710:Homocysteine / Q000378:metabolism; D006801:Humans; D008297:Male; D008661:Metabolism, Inborn Errors / Q000201:enzymology*; D008745:Methylation; D008754:Methylenetetrahydrofolate Dehydrogenase (NADP) / Q000172:deficiency*; D008780:Methyltransferases / Q000378:metabolism; D010088:Oxidoreductases / Q000172:deficiency*; D012559:Schizophrenia / Q000188:drug therapy / Q000201:enzymology* / Q000378:metabolism; D013763:Tetrahydrofolates / Q000378:metabolism
D013763:Tetrahydrofolates; D006710:Homocysteine; D005492:Folic Acid; D010088:Oxidoreductases; D008754:Methylenetetrahydrofolate Dehydrogenase (NADP); D008780:Methyltransferases; D004298:Dopamine